Today’s Watch List: Genworth Financial (NYSE:GNW), Cellular Biomedicine (NASDAQ:CBMG), B/E Aerospace Inc. (NASDAQ:BEAV), R.R. Donnelley & Sons (NASDAQ:RRD), Regeneron Pharmaceuticals (NASDAQ:REGN)

On Thursday shares of Genworth Financial, Inc. (NYSE:GNW) closed at $8.25. Company’s sales growth for last 5 years was 1.10% and EPS growth for next 5 years is recorded as 5.00%. Analysts at Jefferies Group increased their target price on shares of Genworth Financial Inc (NYSE:GNW) from $10.00 to $12.00 in a research report issued to clients and investors on Wednesday. The firm currently has a “buy” rating on the stock. Jefferies Group’s target price indicates a potential upside of 44.06% from the company’s current price.

Cellular Biomedicine Group Inc. (NASDAQ:CBMG) in last trading activity increased 11.76% to close at $26.70. Company weekly performance is 8.85% while its quarterly performance stands at 42.63%. Cellular Biomedicine Group Inc. (NASDAQ:CBMG) is -45.51% away from its 52 week high. On April 30, Cellular Biomedicine Group Inc. (Nasdaq:CBMG) announced the appointment of Scott J. Antonia, M.D, Ph.D. and Guoping Fan, Ph.D., as members of the newly established Scientific Advisory Board. Dr. Antonia will advise the company on immuno-oncology and Dr. Fan will advise the company on stem cell technology and its applications.

On last trading day B/E Aerospace Inc. (NASDAQ:BEAV) decreased -0.51% to close at $59.06. Its volatility for the week is 1.80% while volatility for the month is 1.80%. BEAV’s sales growth for past 5 years was 6.00% and its EPS growth for past 5 years was -17.40%. B/E Aerospace Inc. (NASDAQ:BEAV) monthly performance is -5.96%. B/E Aerospace, Inc. (NASDAQ: BEAV) said its board of directors declared a quarterly dividend of USD0.19 per outstanding share of the company´s common stock. The dividend is payable on July 6, 2015 to shareholders of record at the close of business on May 18, 2015.

R.R. Donnelley & Sons Company (NASDAQ:RRD) has 2.10% insider ownership while its institutional ownership stands at 89.40%. In last trading activity company’s stock closed at $18.06. RR Donnelley & Sons Company (NASDAQ:RRD) reported financial results for the first quarter of 2015. Net sales in the quarter were $2.7 billion, up $72.3 million, or 2.7 percent, from the first quarter of 2014, largely due to the acquisitions of Consolidated Graphics and the North American operations of Esselte.

On last trading day Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) decreased -0.30% to close at $468.62. Its volatility for the week is 2.75% while volatility for the month is 2.70%. REGN’s sales growth for past 5 years was 49.40% and its EPS growth for past 5 years was 41.20%. Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) monthly performance is 3.40%. Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) has reported an 11.30 percent rise in profit for the quarter ended Mar. 31, 2015. The company has earned $76.02 million, or $0.66 a share in the quarter, compared with $68.30 million, or $0.61 a share for the same period last year.

Hot Stocks: Millennial Media Inc. (NYSE:MM), Cellular Biomedicine Group Inc. (NASDAQ:CBMG), Lindsay Corporation (NYSE:LNN), KNOT Offshore Partners LP (NYSE:KNOP), Avery Dennison (NYSE:AVY)

On Wednesday shares of Millennial Media Inc. (NYSE:MM) closed at $1.57. Company’s sales growth for last 5 years was 78.80% and EPS growth for next 5 years is recorded as 45.00%. Millennial Media Inc. (NYSE:MM) on 5 May, reported a loss of $19.8 million in its first quarter. On a per-share basis, the Baltimore-based company said it had a loss of 14 cents. Losses, adjusted for amortization costs and stock option expense, came to 9 cents per share. The mobile advertising company posted revenue of $63.2 million in the period. For the current quarter ending in June, Millennial Media said it expects revenue in the range of $68 million to $71 million. The company expects full-year revenue in the range of $311 million to $342 million.

Cellular Biomedicine Group Inc. (NASDAQ:CBMG) in last trading activity moved up 1.49% to close at $23.89. Company weekly performance is -9.51% while its quarterly performance stands at 46.47%. Cellular Biomedicine Group Inc. (NASDAQ:CBMG) is -51.24% away from its 52 week high. Cellular Biomedicine Group Inc. (NASDAQ:CBMG) on 30 April, announced that it intends to vigorously defend against the claims made in a putative securities class action lawsuit filed against the company and two of its officers in the United States District Court for the Northern District of California.

On last trading day Lindsay Corporation (NYSE:LNN) moved up 0.57% to close at $77.89. Its volatility for the week is 2.63% while volatility for the month is 2.28%. LNN’s sales growth for past 5 years was 12.90% and its EPS growth for past 5 years was 29.20%. Lindsay Corporation (NYSE:LNN) monthly performance is 3.66%. Lindsay Corporation (NYSE: LNN) announced that its Board of Directors has declared a regular quarterly cash dividend of $0.27 per share, payable May 29, 2015, to shareholders of record on May 15, 2015.

KNOT Offshore Partners LP (NYSE:KNOP) has institutional ownership stands at 81.30%. In last trading activity company’s stock closed at $22.75. KNOT Offshore Partners (NASDAQ:KNOP)‘s stock had its “hold” rating reissued by Zacks
in a research note issued on 30 April.

On last trading day Avery Dennison Corporation (NYSE:AVY) moved up 1.49% to close at $57.72. Its volatility for the week is 2.13% while volatility for the month is 1.46%. AVY’s sales growth for past 5 years was 4.10% and its EPS growth for past 5 years was 18.40%. Avery Dennison Corporation (NYSE:AVY) monthly performance is 8.27%. Avery Dennison Corporation (NYSE:AVY) on 30 April, announced preliminary, unaudited results for its first quarter ended April 4, 2015. In the first quarter, the company realized approximately $10 million in savings from restructuring, net of transition costs, and incurred restructuring charges of approximately $14 million, nearly all of which represent cash costs.

Moving Stocks: Cellular Biomedicine Group Inc. (NASDAQ:CBMG), xG Technology (NASDAQ:XGTI), Chesapeake Energy Corporation (NYSE:CHK), Dresser-Rand Group Inc. (NYSE:DRC), DineEquity (NYSE:DIN)

On Friday shares of Cellular Biomedicine Group Inc. (NASDAQ:CBMG) closed at $23.96. Company’s sales growth for last 5 years was 43.10%. On April 30, Cellular Biomedicine Group Inc. (NASDAQ:CBMG) announced that it intends to vigorously defend against the claims made in a putative securities class action lawsuit filed against the company and two of its officers in the United States District Court for the Northern District of California. The complaint is based in large part on an anonymous article published on the Seeking Alpha website, which CBMG has already addressed on its website. CBMG has reviewed the complaint and views the allegations as meritless.

xG Technology, Inc. (NASDAQ:XGTI) in last trading activity increased 15.16% to close at $0.36. Company weekly performance is 73.75% while its quarterly performance stands at -21.74%. xG Technology, Inc. (NASDAQ:XGTI) is -88.04% away from its 52 week high. On Apr. 30, DirectView Holdings, Inc., announced its agreement with xG Technology, Inc. (“xG”) (NASDAQ:XGTI), to integrate DirectView’s body-worn camera with xG’s xMax private mobile broadband technology.

On last trading day Chesapeake Energy Corporation (NYSE:CHK) increased 4.88% to close at $16.54. Its volatility for the week is 4.83% while volatility for the month is 3.62%. CHK’s sales growth for past 5 years was 22.20% and its EPS growth for past 5 years was 16.80%. Chesapeake Energy Corporation (NYSE:CHK) monthly performance is 15.94%. TheStreet reissued their hold rating on shares of Chesapeake Energy (NYSE:CHK) in a research note released on Thursday morning.

Dresser-Rand Group Inc. (NYSE:DRC) has 0.90% insider ownership while its institutional ownership stands at 77.50%. In last trading activity company’s stock closed at $82.86.

On last trading day DineEquity, Inc. (NYSE:DIN) moved down -1.28% to close at $95.20. Its volatility for the week is 3.89% while volatility for the month is 2.22%. DIN’s sales growth for past 5 years was -14.30% and its EPS growth for past 5 years was 28.10%. DineEquity, Inc. (NYSE:DIN) monthly performance is -10.08%. On April 30, DineEquity, Inc. (NYSE:DIN), announced financial results for the first quarter of fiscal 2015. GAAP net income available to common stockholders was $28.0 million for the first quarter of 2015, representing earnings per diluted share of $1.47. This compares to net income available to common stockholders of $20.5 million, representing earnings per diluted share of $1.08, for the first quarter of 2014. The increase was mainly due to a decline in interest expense and higher gross profit from strong same-restaurant sales growth across both brands.

Best Stocks: Argos Therapeutics (NASDAQ:ARGS), Cellular Biomedicine Group Inc. (NASDAQ:CBMG), Terreno Realty Corp. (NYSE:TRNO), Rocky Mountain Chocolate Factory (NASDAQ:RMCF), Rambus (NASDAQ:RMBS)

On Thursday shares of Argos Therapeutics, Inc. (NASDAQ:ARGS) closed at $7.99. Company’s sales growth for last 5 years was -18.00%. Argos Therapeutics Inc. (NASDAQ:ARGS) on 23 April, announced the company received the Economic Development Award at the 17th annual Triangle Commercial Real Estate Women (Triangle CREW) Champion Awards ceremony held at the Embassy Suites in Cary, NC. This year more than 100 companies were nominated for Triangle CREW Champion Awards in 13 different categories. Argos received the Economic Development Award for the company’s plans for expansion and support for job creation and economic growth in the Research Triangle area.

Cellular Biomedicine Group Inc. (NASDAQ:CBMG) in last trading activity decreased -7.08% to close at $24.53. Company weekly performance is -21.78% while its quarterly performance stands at 55.06%. Cellular Biomedicine Group Inc. (NASDAQ:CBMG) is -49.94% away from its 52 week high. Cellular Biomedicine Group Inc. (Nasdaq:CBMG) announced the appointment of Scott J. Antonia, M.D, Ph.D. and Guoping Fan, Ph.D., as members of the newly established Scientific Advisory Board.

On last trading day Terreno Realty Corp. (NYSE:TRNO) decreased -3.97% to close at $21.28. Its volatility for the week is 2.50% while volatility for the month is 2.24%. Terreno Realty Corp. (NYSE:TRNO) monthly performance is -6.01%. It was reported on 20 April, that Terreno Realty Corp. (NYSE:TRNO) has purchased a 115,000-square-foot distribution building at 8420 S. 190th St. in Kent for about $11.2 million. It has 16 loading positions, 14 at dock height and two at grade level. The 6.3-acre site also has parking for 62 vehicles, Terreno said in a press release.

Rocky Mountain Chocolate Factory Inc. (NASDAQ:RMCF) has 14.40% insider ownership while its institutional ownership stands at 36.50%. In last trading activity company’s stock closed at $12.75. U-Swirl, Inc. announced that its wholly-owned subsidiary, U-SWIRL International, which operates and franchises self-serve frozen yogurt cafes, has acquired the business assets of Let’s Yo!, LLC. Rocky Mountain Chocolate Factory, Inc. (NASDAQ:RMCF) owns a controlling interest in U-Swirl, Inc.

On last trading day Rambus Inc. (NASDAQ:RMBS) decreased -1.98% to close at $13.84. Its volatility for the week is 2.88% while volatility for the month is 3.59%. RMBS’s sales growth for past 5 years was 21.30% and its EPS growth for past 5 years was 17.60%. Rambus Inc. (NASDAQ:RMBS) monthly performance is 10.02%. Rambus Inc. (NASDAQ:RMBS) holds a Zacks Rank #2 (Buy).

Active Stocks: Newmont Mining Corporation (NYSE:NEM), Cisco Systems (NASDAQ:CSCO), Cellular Biomedicine Group Inc. (NASDAQ:CBMG), DTE Energy Company (NYSE:DTE), Veracyte (NASDAQ:VCYT)

On Wednesday shares of Newmont Mining Corporation (NYSE:NEM) closed at $23.55. Company’s sales growth for last 5 years was -1.10%. Equities researchers at Deutsche Bank increased their target price on shares of Newmont Mining Corporation (NYSE:NEM) from $21.00 to $23.00 in a research report issued on Monday. The firm currently has a “hold” rating on the stock. Deutsche Bank’s price objective would suggest a potential upside of 2.95% from the company’s current price.

On Wednesday shares of Cisco Systems, Inc. (NASDAQ:CSCO) closed at $28.25. Company’s sales growth for last 5 years was 5.50% and EPS growth for next 5 years is recorded as 8.17%. Cisco Systems, Inc. (NASDAQ:CSCO) unveiled a host of new capabilities and services that give security professionals extensive intelligence and analysis on potential compromises and solutions to protect against, respond to and recover from attacks.

Cellular Biomedicine Group Inc. (NASDAQ:CBMG) in last trading activity fell -4.17% to close at $29.61. Company weekly performance is 8.82% while its quarterly performance stands at 65.05%. Cellular Biomedicine Group Inc. (NASDAQ:CBMG) is -39.57% away from its 52 week high. Cellular Biomedicine Group Inc. (NASDAQ:CBMG) announced that they have been selected to present at the seventh annual ChinaBio® Partnering Forum 2015 to be held in Shanghai (April 15–16, 2015) at the Kerry Hotel Pudong in Shanghai, China. This life science industry event is expected to attract over 800 attendees from around the world focused on developing cross-border relationships in China.

On last trading day DTE Energy Company (NYSE:DTE) advanced 0.07% to close at $81.48. Its volatility for the week is 1.07% while volatility for the month is 1.59%. DTE’s sales growth for past 5 years was 8.90% and its EPS growth for past 5 years was 9.50%. DTE Energy Company (NYSE:DTE) monthly performance is 3.18%. On 12 April, DTE Energy Company (NYSE:DTE) said that, Paula Silver has been named vice president of corporate communications at Detroit-based DTE Energy Co.

Veracyte, Inc. (NASDAQ:VCYT) has 50.95% insider ownership while its institutional ownership stands at 85.70%. In last trading activity company’s stock closed at $8.90. Veracyte, Inc. (NASDAQ:VCYT) and GE announced a research collaboration to develop new solutions that can improve disease diagnosis. Financial and other terms were not disclosed.

Hot Watch List: Cisco Systems (NASDAQ:CSCO), Cellular Biomedicine Group Inc. (NASDAQ:CBMG), McCormick & Company, Incorporated (NYSE:MKC), DTE Energy Company (NYSE:DTE), Veracyte (NASDAQ:VCYT)

On Tuesday shares of Cisco Systems, Inc. (NASDAQ:CSCO) closed at $27.81. Company’s sales growth for last 5 years was 5.50% and EPS growth for next 5 years is recorded as 8.17%. Cisco Systems, Inc. (NASDAQ:CSCO) unveiled a host of new capabilities and services that give security professionals extensive intelligence and analysis on potential compromises and solutions to protect against, respond to and recover from attacks.

Cellular Biomedicine Group Inc. (NASDAQ:CBMG) in last trading activity moved up 2.15% to close at $30.90. Company weekly performance is 22.52% while its quarterly performance stands at 61.02%. Cellular Biomedicine Group Inc. (NASDAQ:CBMG) is -36.94% away from its 52 week high. Cellular Biomedicine Group Inc. (NASDAQ:CBMG) announced that they have been selected to present at the seventh annual ChinaBio® Partnering Forum 2015 to be held in Shanghai (April 15–16, 2015) at the Kerry Hotel Pudong in Shanghai, China. This life science industry event is expected to attract over 800 attendees from around the world focused on developing cross-border relationships in China.

On last trading day McCormick & Company, Incorporated (NYSE:MKC) moved up 0.32% to close at $77.79. Its volatility for the week is 1.03% while volatility for the month is 1.48%. MKC’s sales growth for past 5 years was 5.90% and its EPS growth for past 5 years was 8.00%. McCormick & Company, Incorporated (NYSE:MKC) monthly performance is 8.63%. McCormick & Company, Incorporated (NYSE:MKC)‘s stock had its “hold” rating reiterated by research analysts at JPMorgan Chase & Co. in a report released on Wednesday. They currently have a $71.00 price objective on the stock, up from their previous price objective of $67.00. JPMorgan Chase & Co.’s price target points to a potential downside of 6.57% from the company’s current price.

DTE Energy Company (NYSE:DTE) has 0.30% insider ownership while its institutional ownership stands at 63.90%. In last trading activity company’s stock closed at $81.42. On 12 April, DTE Energy Company (NYSE:DTE) said that, Paula Silver has been named vice president of corporate communications at Detroit-based DTE Energy Co.

On last trading day Veracyte, Inc. (NASDAQ:VCYT) moved up 6.86% to close at $8.88. Its volatility for the week is 4.42% while volatility for the month is 5.78%. Veracyte, Inc. (NASDAQ:VCYT) monthly performance is 15.63%. Veracyte, Inc. (NASDAQ:VCYT) and GE announced a research collaboration to develop new solutions that can improve disease diagnosis. Financial and other terms were not disclosed.

5 Stocks under Wall Street’s Radar: Cellular Biomedicine (NASDAQ:CBMG), Corning Inc. (NYSE:GLW), Pinnacle Foods (NYSE:PF), Talisman Energy (NYSE:TLM), SkyPeople Fruit Juice (NASDAQ:SPU)

On Wednesday shares of Cellular Biomedicine Group Inc. (NASDAQ:CBMG) closed at $27.21. Company’s sales growth for last 5 years was 43.10% Cellular Biomedicine Group Inc. (NASDAQ:CBMG) announced the Company will host an open house titled “Advancing Solutions to Cancerous and Degenerative Straits” following the China BIO conference in Shanghai on April 17, 2015 beginning at 8:30 a.m. located at the Company’s facility at 333 Guiping Road, Building 1, Caohejing High Technology Park, Shanghai, China.

Corning Inc. (NYSE:GLW) in last trading activity increased 0.27% to close at $22.06. Company weekly performance is -2.73% while its quarterly performance stands at -0.59%. Corning Inc. (NYSE:GLW) is -11.88% away from its 52 week high. On 1 April, Corning Inc. (NYSE:GLW) said that, it has acquired iBwave Solutions, Inc., a design software company based in Montreal, Canada.

On last trading day Pinnacle Foods Inc. (NYSE:PF) increased 1.36% to close at $41.78. Its volatility for the week is 1.73% while volatility for the month is 1.94%. PF’s sales growth for past 5 years was 9.50% and its EPS growth for past 5 years was -17.30%. Pinnacle Foods Inc. (NYSE:PF) monthly performance is 12.89%. Pinnacle Foods Inc. (NYSE:PF) said that, it opened, manufacturing for its recently-acquired Wish-Bone® salad dressings business in St. Elmo, Illinois.

Talisman Energy Inc. (NYSE:TLM) has 6.01% insider ownership while its institutional ownership stands at 76.10%. In last trading activity company’s stock closed at $7.78. Talisman Energy Inc. (NYSE:TLM) declared a dividend on the company’s common shares of US$0.1125 per share. The dividend will be paid on April 29, 2015 to shareholders of record at the close of business on April 20, 2015.

On last trading day SkyPeople Fruit Juice, Inc. (NASDAQ:SPU) increased 1.75% to close at $1.16. Its volatility for the week is 4.03% while volatility for the month is 5.81%. SPU’s sales growth for past 5 years was 10.90% and its EPS growth for past 5 years was -8.20%. SkyPeople Fruit Juice, Inc. (NASDAQ:SPU) monthly performance is -3.33%. On 31 March, SkyPeople Fruit Juice, Inc. (NASDAQ:SPU) announced its financial results for the fiscal year ended December 31, 2014. Revenue for the twelve months ended December 31, 2014 was $99.1 million, an increase of 25%, as compared to $79.0 million for fiscal 2013.

Hot Alert: Cellular Biomedicine (NASDAQ:CBMG), Southwestern Energy Co. (NYSE:SWN), Summit Midstream Partners (NYSE:SMLP), Pacific Sunwear of California (NASDAQ:PSUN), Red Hat (NYSE:RHT)

On Wednesday shares of Cellular Biomedicine Group Inc. (NASDAQ:CBMG) closed at $43.03. Cellular Biomedicine Group Inc. (NASDAQ:CBMG) announced clinical data from its CAR-T immuno-oncology clinical development programs. The data discussed by Dr. Wei (William) Cao, PhD, BM, Chief Executive Officer of Cellular Biomedicine Group, at the 2015 Annual Regen Med Investor Day on March 25 in New York City.

Southwestern Energy Co. (NYSE:SWN) in last trading activity advanced 1.92% to close at $23.32. Company weekly performance is -1.44% while its quarterly performance stands at -20.44%. Southwestern Energy Co. (NYSE:SWN) is -52.56% away from its 52 week high. Southwestern Energy Company (NYSE:SWN) announced that its Board of Directors declared a quarterly dividend of $14.5833 per share on its 6.25% Series B Mandatory Convertible Preferred Stock, payable on April 15, 2015, to holders of record on April 1, 2015. This equates to $0.72917 for each depositary share, which represents a 1/20th interest in a share of the Series B preferred stock. The dividend is for the initial dividend period beginning on January 21, 2015 and ending on April 14, 2015.

On last trading day Summit Midstream Partners, LP (NYSE:SMLP) decreased -0.52% to close at $32.69. Its volatility for the week is 3.96% while volatility for the month is 4.67%. SMLP’s sales growth for past 5 years was 147.10% and its EPS growth for past 5 years was -19.48%. Summit Midstream Partners, LP (NYSE:SMLP) monthly performance is -12.38%. Zacks downgraded shares of Summit Midstream Partners (NYSE:SMLP) from a neutral rating to an underperform rating in a research note released on Thursday morning. They currently have $32.80 target price on the stock.

Pacific Sunwear of California Inc. (NASDAQ:PSUN) has 1.20% insider ownership while its institutional ownership stands at 51.60%. In last trading activity company’s stock closed at $2.87. Pacific Sunwear of California Inc. (NASDAQ:PSUN) posted quarterly net income of $48 million, or $0.26 per share, versus $45 million, or $0.24 per share, in the year-earlier period. Excluding items, non-GAAP adjusted net income for the quarter came in at $0.43 per share.

On last trading day Red Hat, Inc. (NYSE:RHT) fell -1.37% to close at $68.45. Its volatility for the week is 2.33% while volatility for the month is 1.87%. RHT’s sales growth for past 5 years was 18.70% and its EPS growth for past 5 years was 19.00%. Red Hat, Inc. (NYSE:RHT) monthly performance is -0.64%. Red Hat, Inc. (NYSE:RHT) reported fourth-quarter profit rose to $47.7 million or $0.26 per share from $45.1 million or $0.24 per share last year. Excluding special items, adjusted earnings for the quarter were $80.6 million or $0.43 per share, up from $75.2 million or $0.39 per share a year ago. On average, 30 analysts polled by Thomson Reuters estimated earnings of $0.41 per share for the quarter. Analysts’ estimates typically exclude special items.

Stocks Getting Hot: Cellular Biomedicine (NASDAQ:CBMG), Banco Latinoamericano Comerc Exterior (NYSE:BLX), Fox Chase Bancorp (NASDAQ:FXCB), Lincoln National (NYSE:LNC), LightPath Technologies (NASDAQ:LPTH)

Cellular Biomedicine Group Inc. (NASDAQ:CBMG) announced its acquisition of Chinese PLA General Hospital’s (“PLAGH”, Beijing, also known as “301 Hospital”) Chimeric Antigen Receptor T cell (CAR-T) therapy, its recombinant expression vector CD19, CD20, CD30 and Human Epidermal Growth Factor Receptor’s (EGFR or HER1) Immuno-Oncology patents (all pending), and Phase I/II clinical data of the aforementioned therapies and manufacturing knowledge. On Wednesday shares of Cellular Biomedicine Group Inc. (NASDAQ:CBMG) closed at $25.00.

On 11 February, Banco Latinoamericano Comerc Exterior SA (NYSE:BLX) announced its results for the fourth quarter and full-year ended December 31, 2014. Bladex’s fourth quarter 2014 Net Income totaled $36.1 million (+51% YoY; +36% QoQ). Full-year 2014 Net Income of $106.9 million (+$22 million, or +26% YoY), on improved results in core business segments (business net income of $103.5 million versus$89.4 million in 2013) and non-core activities. Banco Latinoamericano Comerc Exterior SA (NYSE:BLX) in last trading activity advanced 9.71% to close at $32.09. Company weekly performance is 12.72% while its quarterly performance stands at -2.08%. Banco Latinoamericano Comerc Exterior SA (NYSE:BLX) is -5.89% away from its 52 week high.

On 28 January, Fox Chase Bancorp, Inc. (NASDAQ:FXCB) announced net income of $8.2 million, or $0.71 per diluted share, for the year ended December 31, 2014, compared to $5.5 million, or $0.48 per diluted share, for the year ended December 31, 2013. The Company reported net income of $2.1 million, or $0.19 per diluted share, for the quarter ended December 31, 2014 compared to net income of $1.5 million, or $0.13 per diluted share, for the quarter ended December 31, 2013. On last trading day Fox Chase Bancorp, Inc. (NASDAQ:FXCB) advanced 0.31% to close at $16.19. Its volatility for the week is 1.29% while volatility for the month is 1.16%. FXCB’s sales growth for past 5 years was -4.80% and its EPS growth for past 5 years was 64.80%. Fox Chase Bancorp, Inc. (NASDAQ:FXCB) monthly performance is -2.47%.

On 5 February, Lincoln National Corporation (NYSE:LNC) reported fourth-quarter 2014 operating earnings of $1.67 per share. Lincoln National’s total operating revenue increased 20.3% from the prior-year quarter to $3.8 billion, beating the Zacks Consensus Estimate of $3.3 billion. Lincoln National Corporation (NYSE:LNC) has 0.20% insider ownership while its institutional ownership stands at 84.30%. In last trading activity company’s stock closed at $57.82.

On 2 February, LightPath Technologies, Inc. (NASDAQ:LPTH) announced the implementation of strategic growth initiatives and an organizational optimization plan. Under these plans, the Company will be better positioned to accelerate its revenue growth and profitability, principally by the transition to a technical sales process that leverages the success of its existing demand-creation model. On last trading day LightPath Technologies, Inc. (NASDAQ:LPTH) fell -0.84% to close at $1.18. Its volatility for the week is 11.36% while volatility for the month is 7.09%. LPTH’s sales growth for past 5 years was 9.50% and its EPS growth for past 5 years was 49.70%. LightPath Technologies, Inc. (NASDAQ:LPTH) monthly performance is -7.09%.

Investor’s pick: Cellular Biomedicine Group Inc. (NASDAQ:CBMG), Frontier Communications (NASDAQ:FTR), Inovio Pharmaceuticals (NASDAQ:INO), Main Street Capital (NYSE:MAIN), Berry Plastics Group (NYSE:BERY)

Cellular Biomedicine Group Inc. (NASDAQ:CBMG) announced its acquisition of Chinese PLA General Hospital’s (“PLAGH”, Beijing, also known as “301 Hospital”) Chimeric Antigen Receptor T cell (CAR-T) therapy, its recombinant expression vector CD19, CD20, CD30 and Human Epidermal Growth Factor Receptor’s (EGFR or HER1) Immuno-Oncology patents (all pending), and Phase I/II clinical data of the aforementioned therapies and manufacturing knowledge. On Tuesday shares of Cellular Biomedicine Group Inc. (NASDAQ:CBMG) closed at $23.60.

On 5 February, Frontier Communications Corporation (NASDAQ:FTR) announced a definitive agreement with Verizon Communications Inc. (NYSE:VZ) under which Frontier will acquire Verizon’s wireline operations that provide services to residential, commercial and wholesale customers in California, Florida and Texas, for $10.54 billion in cash. Frontier Communications Corporation (NASDAQ:FTR) in last trading activity advanced 2.10% to close at $8.26. Company weekly performance is 12.53% while its quarterly performance stands at 30.28%. Frontier Communications Corporation (NASDAQ:FTR) is 1.98% away from its 52 week high.

On 29 January, Inovio Pharmaceuticals, Inc. (NASDAQ:INO) announced it has appointed Mark Stephen Gelder, M.D. as Vice President, Clinical Development. Dr. Gelder will be responsible for planning and executing Inovio’s clinical development strategy for its immunotherapies against human papillomavirus (HPV)-caused cervical cancer and dysplasia. He will report to Dr. Mark Bagarazzi, Inovio’s Chief Medical Officer. On last trading day Inovio Pharmaceuticals, Inc. (NASDAQ:INO) moved down -3.16% to close at $7.66. Its volatility for the week is 4.76% while volatility for the month is 4.50%. INO’s sales growth for past 5 years was 45.10% and its EPS growth for past 5 years was -3.90%. Inovio Pharmaceuticals, Inc. (NASDAQ:INO) monthly performance is -19.28%.

Main Street Capital Corporation (NYSE:MAIN) announced that it will release its fourth quarter and full year 2014 results on Thursday, February 26, 2015, after the market closes. Main Street Capital Corporation (NYSE:MAIN) has 5.80% insider ownership while its institutional ownership stands at 25.50%. In last trading activity company’s stock closed at $30.30.

Zacks upgraded shares of Berry Plastics Group (NYSE:BERY) from a neutral rating to an outperform rating in a report released on Thursday. Zacks currently has $36.50 price objective on the stock. On last trading day Berry Plastics Group, Inc. (NYSE:BERY) advanced 0.84% to close at $34.94. Its volatility for the week is 1.70% while volatility for the month is 2.22%. BERY’s sales growth for past 5 years was 9.20% and its EPS growth for past 5 years was -18.20%. Berry Plastics Group, Inc. (NYSE:BERY) monthly performance is 10.26%.